A real-world pharmacovigilance study of tafasitamab: data mining of the US food and drug administration adverse event reporting system
This study provides additional evidence for risk identification of tafasitamab in the real world, which could help clinicians and pharmacists increase vigilance and improve the safety of tafasitamab in clinical practice.
Authors
- Jiating Liu
- Zhengze Shen (ORCID: https://orcid.org/0000-0002-2752-896X)
- Hongli Wang (ORCID: https://orcid.org/0000-0003-0655-3389)
- Dan Huang (ORCID: https://orcid.org/0000-0003-2595-0785)
- Zhongliang Xu
Institutions
- Chongqing Medical University (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1080/14740338.2024.2416914
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00